Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based Study

BACKGROUND: Myocardial infarction is a cardiac adverse event associated with 5-fluorouracil (5-FU). There are limited data on the incidence, risk, and prognosis of 5-FU-associated myocardial infarction. OBJECTIVES: The aim of this study was to examine the risk for myocardial infarction in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmuganathan, Jan Walter Dhillon, Kragholm, Kristian, Tayal, Bhupendar, Polcwiartek, Christoffer, Poulsen, Laurids Østergaard, El-Galaly, Tarec Christoffer, Fosbøl, Emil Loldrup, D’Souza, Maria, Gislason, Gunnar, Køber, Lars, Schou, Morten, Nielsen, Dorte, Søgaard, Peter, Torp-Pedersen, Christian Tobias, Mamas, Mamas A., Freeman, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702810/
https://www.ncbi.nlm.nih.gov/pubmed/34988482
http://dx.doi.org/10.1016/j.jaccao.2021.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702810/
https://www.ncbi.nlm.nih.gov/pubmed/34988482
http://dx.doi.org/10.1016/j.jaccao.2021.11.001

Ejemplares similares